13.01.2013 Views

başkent üniversitesi tıp fakültesi çocuk sağlığı ve hastalıkları ...

başkent üniversitesi tıp fakültesi çocuk sağlığı ve hastalıkları ...

başkent üniversitesi tıp fakültesi çocuk sağlığı ve hastalıkları ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

7. KAYNAKLAR<br />

1. Park CH, Valore EV, Waring AJ, Ganz T. Hepcidin, a urinary antimicrobial peptide<br />

synthesized in the li<strong>ve</strong>r. J Biol Chem 276: 7806–7810, 2001.<br />

2. Kemna EHJM, Tjalsma H, Willems HL, Swinkels DW. Hepcidin: from disco<strong>ve</strong>ry to<br />

differential diagnosis. Haematologica 93: 90–97, 2008.<br />

3. Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brissot P, Loreal O. A new mouse<br />

li<strong>ve</strong>r-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is<br />

o<strong>ve</strong>rexpressed during iron o<strong>ve</strong>rload. J Biol Chem 276: 7811–7819, 2001.<br />

4. Hunter HN, Fulton DB, Ganz T, Vogel HJ. The solution structure of human hepcidin, a<br />

peptide hormone with antimicrobial activity that is invol<strong>ve</strong>d in iron uptake and hereditary<br />

hemochromatosis. J Biol Chem 277: 37597–37603, 2002.<br />

5. Ri<strong>ve</strong>ra S, Nemeth E, Gabayan V, Lopez MA, Farshidi D, Ganz T. Synthetic hepcidin causes<br />

rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs. Blood<br />

106: 2196–2199, 2005.<br />

6. Nemeth E, Preza GC, Jung CL, Kaplan J, Waring AJ, Ganz T. The N-terminus of hepcidin is<br />

essential for its interaction with ferroportin: Structure-function study. Blood 107: 328–333,<br />

2006.<br />

7. Pietrangelo A: Hereditary hemochromatosis. Annu Rev Nutr 26: 251–270, 2006.<br />

8. Iglesias-Berengue J, Lopez-Espinosa JA, Ortega-Lopez J, Sanchez-Sanchez L, Asensio-<br />

Llorente M, Margarit-Creixell C, Diaz-Heredia C. Hematologic abnormalities in li<strong>ve</strong>rtransplanted<br />

children during medium- to long-term follow-up. Transplant Proc 35: 1904-1906,<br />

2003.<br />

9. Maheshwari A, Mishra R, Thuluvath PJ. Post-li<strong>ve</strong>r-transplant anemia: etiology and<br />

management. Li<strong>ve</strong>r Transpl 10: 165-173, 2004.<br />

10. Ganz T. Molecular control of iron transport. J Am Soc Nephrol 18: 394–400, 2007.<br />

11. Ganz T. Hepcidin in iron metabolism. Curr Opin Hematol 11: 251-254, 2004.<br />

12. Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of<br />

inflammation. Blood 102:783-788, 2003.<br />

13. Ganz T. Nemeth E. Iron imports. IV. Hepcidin and regulation of body iron metabolism.<br />

Am J Physiol Gastrointest Li<strong>ve</strong>r Physiol 290: 199-203, 2006.<br />

14. Andrews NJ. Disorders of iron metabolism. N Engl J Med 341: 1986–1995, 1999.<br />

15. Shayeghi M, Latunde-Dada GO, Oakhill JS, Laftah AH, Takeuchi K, Halliday N, Khan Y,<br />

Warley A, McCann FE, Hider RC, Frazer DM, Anderson GJ, Vulpe CD, Simpson RJ, McKie<br />

AT. Identification of an intestinal heme transporter. Cell 122: 789–801, 2005.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!